Search
Patexia Research
Case number 2017-2056

Apotex Inc. v. Alcon Research, Ltd. > Documents

Date Field Doc. No.Description (Pages)
Jun 12, 2017 33 ORDER granting motion to terminate appeal [32] filed by Appellant Apotex Inc.; issuing mandate. Service as of this date by Clerk of Court. [438350] [MJL] [Entered: 06/12/2017 12:28 PM] (2)
Jun 12, 2017 32 MOTION of Appellant Apotex Inc. to terminate appeal through Voluntary Dismissal. [Consent: unopposed]. Service: 06/12/2017 by email. [438310] [Stephen Auten] [Entered: 06/12/2017 11:36 AM] (5)
Jun 12, 2017 31 Notice of Rejection to Appellant Apotex Inc., the following document cannot be filed: party document [30]. Reason: see attached. [438193] [MJL] [Entered: 06/12/2017 09:17 AM] (1)
Jun 9, 2017 30 Stipulation to Dismiss Appeal for Appellant Apotex Inc.. Service: 06/09/2017 by email. [438103]. This document has been rejected for filing. See Doc. No. [31]. [Stephen Auten] [Entered: 06/09/2017 04:44 PM] (0)
Jun 6, 2017 29 Entry of appearance for Joshua James Bone as of counsel for Appellee Barr Laboratories, Inc.. Service: 06/06/2017 by email. [436681] [Joshua Bone] [Entered: 06/06/2017 01:03 PM] (2)
May 26, 2017 28 Docketing Statement for the Appellee Barr Laboratories, Inc.. Service: 05/26/2017 by email. [434629] [William Jay] [Entered: 05/26/2017 04:12 PM] (4)
May 26, 2017 27 Amended Certificate of Interest for the Appellee Barr Laboratories, Inc.. Service: 05/26/2017 by email. [434625] [William Jay] [Entered: 05/26/2017 04:08 PM] (3)
May 26, 2017 26 Transcript Purchase Order Form for the Appellant Apotex Inc. indicating that a transcript is not needed for the appeal. Service: 05/26/2017 by email. [434496] [Stephen Auten] [Entered: 05/26/2017 01:11 PM] (2)
May 26, 2017 25 Docketing Statement for the Appellant Apotex Inc.. Service: 05/26/2017 by email. [434495] [Stephen Auten] [Entered: 05/26/2017 01:10 PM] (4)
May 26, 2017 24 Certificate of Interest for the Appellant Apotex Inc.. Service: 05/26/2017 by email. [434493] [Stephen Auten] [Entered: 05/26/2017 01:09 PM] (3)
May 25, 2017 17 Corrected Entry of appearance for Stephen R. Auten as principal counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434166] [Stephen Auten] [Entered: 05/25/2017 02:29 PM] (2)
May 25, 2017 12 ORDER filed. The motion [11] is granted to the extent that Apotex’s opening brief is due no later than June 16, 2017, Appellees’ response briefs are due no later than July 14, 2017, Apotex’s reply brief and the joint appendix are due no later than July 26, 2017. The case will be placed on the oral argument calendar after briefing is completed. Service: 05/25/2017 by clerk. [434094] [LMS] [Entered: 05/25/2017 11:22 AM] (2)
May 25, 2017 13 Entry of appearance for William R. Zimmerman as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434152] [William Zimmerman] [Entered: 05/25/2017 01:31 PM] (2)
May 25, 2017 14 Entry of appearance for Joseph M. Reisman as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434155] [Joseph Reisman] [Entered: 05/25/2017 01:39 PM] (2)
May 25, 2017 15 Entry of appearance for Thomas P. Krzeminski as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434160] [Thomas Krzeminski] [Entered: 05/25/2017 01:43 PM] (0)
May 25, 2017 16 Entry of appearance for Richard T. Ruzich as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434165] [Stephen Auten] [Entered: 05/25/2017 01:52 PM] (1)
May 25, 2017 18 Corrected Entry of appearance for Richard T. Ruzich as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434168] [Stephen Auten] [Entered: 05/25/2017 02:32 PM] (2)
May 25, 2017 19 Entry of appearance for John B. Nalbandian as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434170] [Stephen Auten] [Entered: 05/25/2017 02:36 PM] (2)
May 25, 2017 20 NOTICE OF DEFICIENCY: The entry of appearance for Thomas P. Krzeminski [15] filed by Appellant Apotex Inc. in 17-2056 is not signed and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [434193] [MJL] [Entered: 05/25/2017 03:26 PM] (0)
May 25, 2017 21 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information included on the entry of appearance for Joseph M. Reisman [14] does not match the information in the attorney's user account. CORRECTION: Please update as needed to ensure the contact information on the entry of appearance and in the user account matches. [434196] [MJL] [Entered: 05/25/2017 03:29 PM] (0)
May 25, 2017 22 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: John B. Nalbandian (EOA [19]) is not a registered filer with CM/ECF for the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [434197] [MJL] [Entered: 05/25/2017 03:31 PM] (0)
May 25, 2017 23 Corrected Entry of appearance for Thomas P. Krzeminski as of counsel for Appellant Apotex Inc.. Service: 05/25/2017 by email. [434253] [Thomas Krzeminski] [Entered: 05/25/2017 04:33 PM] (2)
May 24, 2017 11 MOTION of Appellant Apotex Inc. to expedite case. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/24/2017 by email. [433973] [Stephen Auten] [Entered: 05/24/2017 08:38 PM] (33)
May 24, 2017 10 Entry of appearance for Stephen R. Auten as principal counsel for Appellant Apotex Inc.. Service: 05/24/2017 by email. [433972] [Stephen Auten] [Entered: 05/24/2017 08:26 PM] (1)
May 23, 2017 9 Entry of appearance for Christopher T. Holding as of counsel for Appellee Barr Laboratories, Inc.. Service: 05/23/2017 by email. [433666] [Christopher Holding] [Entered: 05/23/2017 05:19 PM] (2)
May 23, 2017 8 Certificate of Interest for the Appellee Barr Laboratories, Inc.. Service: 05/23/2017 by email. [433665] [William Jay] [Entered: 05/23/2017 05:15 PM] (3)
May 23, 2017 7 Entry of appearance for William M. Jay as principal counsel for Appellee Barr Laboratories, Inc.. Service: 05/23/2017 by email. [433664] [William Jay] [Entered: 05/23/2017 05:12 PM] (2)
May 22, 2017 6 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Christopher J. Mandernach (entry of appearance [3]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [433196] [CMP] [Entered: 05/22/2017 01:52 PM] (0)
May 22, 2017 5 Docketing Statement for the Appellees Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd. and Alcon Research, Ltd.. Service: 05/22/2017 by US mail, email. [433133] [Adam Perlman] [Entered: 05/22/2017 11:35 AM] (4)
May 22, 2017 4 Certificate of Interest for the Appellees Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd. and Alcon Research, Ltd.. Service: 05/22/2017 by US mail, email. [433131] [Adam Perlman] [Entered: 05/22/2017 11:34 AM] (2)
May 22, 2017 3 Entry of appearance for Christopher J. Mandernach as of counsel for Appellees Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd. and Alcon Research, Ltd.. Service: 05/22/2017 by US mail, email. [433129] [Adam Perlman] [Entered: 05/22/2017 11:32 AM] (2)
May 22, 2017 2 Entry of appearance for Adam L. Perlman as principal counsel for Appellees Alcon Laboratories, Inc., Alcon Pharmaceuticals Ltd. and Alcon Research, Ltd.. Service: 05/22/2017 by US mail, email. [433128] [Adam Perlman] [Entered: 05/22/2017 11:31 AM] (2)
May 19, 2017 1 Appeal docketed. Received: 05/18/2017. [432735]Entry of Appearance due 06/02/2017. Certificate of Interest due 06/02/2017. Docketing Statement due 06/02/2017. Appellant's brief due 07/18/2017. [MJL] [Entered: 05/19/2017 10:19 AM] (30)
Menu